A novel noncanonical signaling pathway for the μ-opioid receptor

Molecular Pharmacology

Volumn 84, Issue 6, 2013, Pages 844-853

  Zhang, Lei ^a   Loh, Horace H ^a   Law, Ping Yee ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 (3,5 DIBROMO 4 HYDROXYBENZYLIDENE) 1,3 DIHYDRO 5 IODO 2 INDOLONE; 4 AMINO 7 TERT BUTYL 5 (4 CHLOROPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; ADENYLATE CYCLASE INHIBITOR; CYCLIC AMP; G PROTEIN COUPLED RECEPTOR; HETEROTRIMERIC GUANINE NUCLEOTIDE BINDING PROTEIN; MORPHINE; MU OPIATE RECEPTOR; NALOXONE; PROTEIN TYROSINE KINASE; RAF PROTEIN; RAS PROTEIN; SOS PROTEIN;

ANIMAL CELL; ARTICLE; CELL STRAIN; CELL STRAIN HEK293; COMPLEX FORMATION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PHOSPHORYLATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADENYLATE CYCLASE; ENZYME ACTIVATION; GRB2 ADAPTOR PROTEIN; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; HEK293 CELLS; HUMANS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-RAF; RAS PROTEINS; RECEPTORS, OPIOID, MU; SIGNAL TRANSDUCTION; SOS1 PROTEIN; SRC-FAMILY KINASES; TYROSINE;

EID: 84888877100     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.113.088278     Document Type: Article

References (55)

1. Avidor-Reiss T, Nevo I, Levy R, Pfeuffer T, and Vogel Z (1996) Chronic opioid treatment induces adenylyl cyclase V superactivation. Involvement of Gβγ. J Biol Chem 271:21309-21315.
2. Avidor-Reiss T, Nevo I, Saya D, Bayewitch M, and Vogel Z (1997) Opiate-induced adenylyl cyclase superactivation is isozyme-specific. J Biol Chem 272:5040-5047.
3. Baccarini M (2005) Second nature: biological functions of the Raf-1 "kinase". FEBS Lett 579:3271-3277.
4. Belcheva MM, Haas PD, Tan Y, Heaton VM, and Coscia CJ (2002) The fibroblast growth factor receptor is at the site of convergence between mu-opioid receptor and growth factor signaling pathways in rat C6 glioma cells. J Pharmacol Exp Ther 303:909-918.
5. Cao C, Huang X, Han Y, Wan Y, Birnbaumer L, Feng GS, Marshall J, Jiang M, and Chu WM (2009) Gα(i1) and Gα(i3) are required for epidermal growth factor-mediated activation of the Akt-mTORC1 pathway. Sci Signal 2:ra17.
6. Cao W, Luttrell LM, Medvedev AV, Pierce KL, Daniel KW, Dixon TM, Lefkowitz RJ, and Collins S (2000) Direct binding of activated c-Src to the beta 3-adrenergic receptor is required for MAP kinase activation. J Biol Chem 275:38131-38134.
7. Chakrabarti S, Oppermann M, and Gintzler AR (2001) Chronic morphine induces the concomitant phosphorylation and altered association of multiple signaling proteins: a novel mechanism for modulating cell signaling. Proc Natl Acad Sci USA 98:4209-4214.
8. Chou JL, Huang CL, Lai HL, Hung AC, Chien CL, Kao YY, and Chern Y (2004) Regulation of type VI adenylyl cyclase by Snapin, a SNAP25-binding protein. J Biol Chem 279:46271-46279.
9. Dalle S, Ricketts W, Imamura T, Vollenweider P, and Olefsky JM (2001) Insulin and insulin-like growth factor I receptors utilize different G protein signaling components. J Biol Chem 276:15688-15695.
10. Daub H, Weiss FU, Wallasch C, and Ullrich A (1996) Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors. Nature 379:557-560.
11. Dhillon AS, Pollock C, Steen H, Shaw PE, Mischak H, and Kolch W (2002) Cyclic AMP-dependent kinase regulates Raf-1 kinase mainly by phosphorylation of serine 259. Mol Cell Biol 22:3237-3246.
12. Ding Q, Gros R, Gray ID, Taussig R, Ferguson SS, and Feldman RD (2004) Raf kinase activation of adenylyl cyclases: isoform-selective regulation. Mol Pharmacol 66:921-928.
13. Fan G, Shumay E, Malbon CC, and Wang H (2001) c-Src tyrosine kinase binds the beta 2-adrenergic receptor via phospho-Tyr-350, phosphorylates G-protein-linked receptor kinase 2, and mediates agonist-induced receptor desensitization. J Biol Chem 276:13240-13247.
14. Faure M, Voyno-Yasenetskaya TA, and Bourne HR (1994) cAMP and beta gamma subunits of heterotrimeric G proteins stimulate the mitogen-activated protein kinase pathway in COS-7 cells. J Biol Chem 269:7851-7854.
15. Gao X and Patel TB (2005) Histidine residues 912 and 913 in protein associated with Myc are necessary for the inhibition of adenylyl cyclase activity. Mol Pharmacol 67:42-49.
16. Gschwind A, Zwick E, Prenzel N, Leserer M, and Ullrich A (2001) Cell communication networks: epidermal growth factor receptor transactivation as the paradigm for interreceptor signal transmission. Oncogene 20:1594-1600.
17. Herrlich A, Daub H, Knebel A, Herrlich P, Ullrich A, Schultz G, and Gudermann T (1998) Ligand-independent activation of platelet-derived growth factor receptor is a necessary intermediate in lysophosphatidic, acid-stimulated mitogenic activity in L cells. Proc Natl Acad Sci USA 95:8985-8990.
18. Kalmes A, Vesti BR, Daum G, Abraham JA, and Clowes AW (2000) Heparin blockade of thrombin-induced smooth muscle cell migration involves inhibition of epidermal growth factor (EGF) receptor transactivation by heparin-binding EGF-like growth factor. Circ Res 87:92-98.
19. Karoor V, Wang L, Wang HY, and Malbon CC (1998) Insulin stimulates sequestration of beta-adrenergic receptors and enhanced association of beta-adrenergic receptors with Grb2 via tyrosine 350. J Biol Chem 273:33035-33041.
20. King AJ, Sun H, Diaz B, Barnard D, Miao W, Bagrodia S, and Marshall MS (1998) The protein kinase Pak3 positively regulates Raf-1 activity through phosphorylation of serine 338. Nature 396:180-183.
21. Koch WJ, Hawes BE, Allen LF, and Lefkowitz RJ (1994) Direct evidence that Gicoupled receptor stimulation of mitogen-activated protein kinase is mediated by G beta gamma activation of p21ras. Proc Natl Acad Sci USA 91:12706-12710.
22. Kolch W (2002) Ras/Raf signalling and emerging pharmacotherapeutic targets. Expert Opin Pharmacother 3:709-718.
23. Kolch W, Heidecker G, Kochs G, Hummel R, Vahidi H, Mischak H, Finkenzeller G, Marmé D, and Rapp UR (1993) Protein kinase C alpha activates RAF-1 by direct phosphorylation. Nature 364:249-252.
24. Koob GF and Bloom FE (1988) Cellular and molecular mechanisms of drug dependence. Science 242:715-723.
25. Law PY, Hom DS, and Loh HH (1982) Loss of opiate receptor activity in neuroblastoma X glioma NG108-15 hybrid cells after chronic opiate treatment. A multiple-step process. Mol Pharmacol 22:1-4.
26. Law PY, Hom DS, and Loh HH (1983) Opiate receptor down-regulation and desensitization in neuroblastoma X glioma NG108-15 hybrid cells are two separate cellular adaptation processes. Mol Pharmacol 24:413-424.
27. Law PY, Wong YH, and Loh HH (2000) Molecular mechanisms and regulation of opioid receptor signaling. Annu Rev Pharmacol Toxicol 40:389-430.
28. Lefkowitz RJ and Shenoy SK (2005) Transduction of receptor signals by beta-arrestins. Science 308:512-517.
29. Li LY and Chang KJ (1996) The stimulatory effect of opioids on mitogen-activated protein kinase in Chinese hamster ovary cells transfected to express mu-opioid receptors. Mol Pharmacol 50:599-602.
30. Liang MN and Garrison JC (1991) The epidermal growth factor receptor is coupled to a pertussis toxin-sensitive guanine nucleotide regulatory protein in rat hepatocytes. J Biol Chem 266:13342-13349.
31. Luttrell L, Kilgour E, Larner J, and Romero G (1990) A pertussis toxin-sensitive G-protein mediates some aspects of insulin action in BC3H-1 murine myocytes. J Biol Chem 265:16873-16879.
32. Luttrell LM, Daaka Y, and Lefkowitz RJ (1999a) Regulation of tyrosine kinase cascades by G-protein-coupled receptors. Curr Opin Cell Biol 11:177-183.
33. Luttrell LM, Ferguson SS, Daaka Y, Miller WE, Maudsley S, Della Rocca GJ, Lin F, Kawakatsu H, Owada K, and Luttrell DK et al. (1999b) Beta-arrestin-dependent formation of β2 adrenergic receptor-Src protein kinase complexes. Science 283: 655-661.
34. Marais R, Light Y, Paterson HF, and Marshall CJ (1995) Ras recruits Raf-1 to the plasmamembrane for activation by tyrosine phosphorylation. EMBO J 14:3136-3145.
35. McDonald PH, Chow CW, Miller WE, Laporte SA, Field ME, Lin FT, Davis RJ, and Lefkowitz RJ (2000) Beta-arrestin 2: a receptor-regulated MAPK scaffold for the activation of JNK3. Science 290:1574-1577.
36. Pierce KL and Lefkowitz RJ (2001) Classical and new roles of beta-arrestins in the regulation of G-protein-coupled receptors. Nat Rev Neurosci 2:727-733.
37. Pierce KL, Tohgo A, Ahn S, Field ME, Luttrell LM, and Lefkowitz RJ (2001) Epidermal growth factor (EGF) receptor-dependent ERK activation by G protein-coupled receptors: a co-culture system for identifying intermediates upstream and downstream of heparin-binding EGF shedding. J Biol Chem 276:23155-23160.
38. Piñeyro G and Archer-Lahlou E (2007) Ligand-specific receptor states: implications for opiate receptor signalling and regulation. Cell Signal 19:8-19.
39. Povsic TJ, Kohout TA, and Lefkowitz RJ (2003) Beta-arrestin1 mediates insulin-like growth factor 1 (IGF-1) activation of phosphatidylinositol 3-kinase (PI3K) and antiapoptosis. J Biol Chem 278:51334-51339.
40. Prenzel N, Zwick E, Daub H, Leserer M, Abraham R, Wallasch C, and Ullrich A (1999) EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature 402:884-888.
41. Roy AA, Baragli A, Bernstein LS, Hepler JR, Hébert TE, and Chidiac P (2006) RGS2 interacts with Gs and adenylyl cyclase in living cells. Cell Signal 18:336-348.
42. Satoh T, Endo M, Nakafuku M, Akiyama T, Yamamoto T, and Kaziro Y (1990) Accumulation of p21ras.GTP in response to stimulation with epidermal growth factor and oncogene products with tyrosine kinase activity. Proc Natl Acad Sci USA 87: 7926-7929.
43. Schallmach E, Steiner D, and Vogel Z (2006) Inhibition of AC-II activity following chronic agonist exposure is modulated by phosphorylation. J Mol Neurosci 29:115-122.
44. Sharma SK, Klee WA, and Nirenberg M (1977) Opiate-dependent modulation of adenylate cyclase. Proc Natl Acad Sci USA 74:3365-3369.
45. 2 receptor in mouse pineal gland tumor cells. J Neurochem 77 :1475-1485.
46. Szücs M, Boda K, and Gintzler AR (2004) Dual effects of DAMGO [D-Ala2,N-Me-Phe4,Gly5-ol]-enkephalin and CTAP (D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen- Thr- NH2) on adenylyl cyclase activity: implications for mu-opioid receptor Gs coupling. J Pharmacol Exp Ther 310:256-262.
47. Tan CM, Kelvin DJ, Litchfield DW, Ferguson SS, and Feldman RD (2001) Tyrosine kinase-mediated serine phosphorylation of adenylyl cyclase. Biochemistry 40: 1702-1709.
48. Tobin AB (2008) G-protein-coupled receptor phosphorylation: where, when and by whom. Br J Pharmacol 153 (Suppl 1):S167-S176.
49. van Biesen T, Hawes BE, Luttrell DK, Krueger KM, Touhara K, Porfiri E, Sakaue M, Luttrell LM, and Lefkowitz RJ (1995) Receptor-tyrosine-kinase- and G beta gamma-mediated MAP kinase activation by a common signalling pathway. Nature 376: 781-784.
50. Varga EV, Rubenzik M, Grife V, Sugiyama M, Stropova D, Roeske WR, and Yamamura HI (2002) Involvement of Raf-1 in chronic delta-opioid receptor agonist-mediated adenylyl cyclase superactivation. Eur J Pharmacol 451:101-102.
51. Walwyn W, Evans CJ, and Hales TG (2007) Beta-arrestin2 and c-Src regulate the constitutive activity and recycling of mu opioid receptors in dorsal root ganglion neurons. J Neurosci 27:5092-5104.
52. Zhang L, Tetrault J, Wang W, Loh HH, and Law PY (2006) Short- and long-term regulation of adenylyl cyclase activity by delta-opioid receptor are mediated by Gai2 in neuroblastoma N2A cells. Mol Pharmacol 69:1810-1819.
53. Zhang L, Zhao H, Qiu Y, Loh HH, and Law PY (2009) Src phosphorylation of microreceptor is responsible for the receptor switching from an inhibitory to a stimulatory signal. J Biol Chem 284:1990-2000.
54. Zimmermann S and Moelling K (1999) Phosphorylation and regulation of Raf by Akt (protein kinase B). Science 286:1741-1744.
55. Zwick E, Daub H, Aoki N, Yamaguchi-Aoki Y, Tinhofer I, Maly K, and Ullrich A (1997) Critical role of calcium-dependent epidermal growth factor receptor trans-activation in PC12 cell membrane depolarization and bradykinin signaling. J Biol Chem 272:24767-24770.